LIVE
4163 · TadawulSAR 18.04+0.34 (+1.92%)
Annual Report 2025

Innovative
Integrated
Healthcare
Services for You

Marking our first year as a publicly listed company on the Saudi Exchange (Tadawul), SMC Healthcare continues its journey of clinical excellence, digital transformation, and sustainable growth across Riyadh.

SAR 1.54B
Net Revenue
+7%
Revenue Growth
581
Inpatient Beds
3,000+
Employees
Listed on Tadawul (Saudi Exchange) — Ticker: 4163 · 25 Jun 2025
2025 Financial Performance

A Year of Strong
Financial Growth

SMC Healthcare delivered robust financial performance in 2025, with revenue growth of 7%, significant margin expansion, and a 43.7% increase in net profit — reflecting the strength of our integrated healthcare platform.

* FY2025 metrics include a SAR 60.6M one-off gain on sale of land.

FY2025 AT A GLANCE
Revenue
SAR 0B
+7%
Net Profit
SAR 0M
+43.7%
EBITDA
SAR 0M
+14.2%
EBITDA Margin
0%
+1.1pp
Fiscal Year ending December 31, 2025
Net Revenue+7.0% YoY
SAR0M
SAR Millions · FY2025
Net Profit+43.7% YoY
SAR0M
Net Margin: 17.3%
EBITDA+25.0% YoY
SAR0M
EBITDA Margin: 27.1%
Total Assets+17.4% YoY
SAR0M
SAR Millions · FY2025
Total Equity+43.6% YoY
SAR0M
SAR Millions · FY2025
Earnings Per Share+43.7% YoY
SAR0.0
EPS · FY2025
Return on Equity+4.2pp YoY
0%
ROE · FY2025
Gross Profit+5.8% YoY
SAR0M
Gross Margin: 24.9%
Financial Performance

Revenue & Profitability Trend

SAR Millions | FY2023–FY2025

202320242025040080012001600
  • Revenue
  • Gross Profit
  • Net Profit
  • EBITDA
Margin Analysis

Margin Expansion Journey

Percentage (%) | FY2023–FY2025

2023202420250%7%14%21%28%
  • Gross Margin
  • Net Margin
  • EBITDA Margin
Balance Sheet Strength

Solid Financial Foundation

SMC's balance sheet reflects a strong capital base, enabling continued investment in expansion while maintaining prudent financial discipline.

SAR 2.4B
Total Assets
+17.4% YoY
SAR 1.2B
Total Equity
+43.6% YoY
SAR 4.51B
Market Cap
At Year End
250M
Shares Issued
Listed Jun 2025
Chairman's Message
Chairman Mr. Sulaiman Al Rashid
Mr. Sulaiman Al Rashid
Chairman of the Board of Directors
SMC Healthcare
Chairman's Message

A Milestone Year
of Transformation

"This year represents a milestone in our evolution: a year in which we transitioned from a private healthcare organization to a publicly listed company positioned for long-term growth, transparency, and value creation."

It is my honor to present our 2025 Annual Report, which is an especially significant publication as it marks our first reporting cycle following SMC's successful listing to the Saudi Stock market on 25 June 2025.

In 2025, our commitment remained clear: Innovative Integrated Healthcare Services for You. This theme reflects who we are today and the healthcare system we are building for tomorrow — one that blends clinical excellence with a human-centred approach.

As we look ahead to 2026, our strategic direction is focused and ambitious. We will continue to strengthen our care model, expand our capabilities, deepen integration across our network, and invest in innovation that improves the patient's journey.

25 Jun 2025
IPO Listing Date
SAR 4.51B
Market Cap at Year End
250M
Shares Issued
CEO & CFO Messages

Building on
Strong Foundations

"The completion of our IPO in 2025 marked a pivotal moment, validating our vision and fueling our future growth opportunities."

Mr. Bassam Chahine, CEO
Mr. Bassam Chahine
Chief Executive Officer, SMC Healthcare

This year was a transformative year for SMC, marked by strong progress across our operations. Our defining milestone was the public listing of the company in the main market of Saudi Exchange (Tadawul).

Operationally, SMC continued to deliver strong performance across its hospital network. Demand for our services remained robust, supported by sustained growth in patient volumes and high utilization across key specialties.

A central focus during the year was strengthening the operational platform required to support long-term growth. We invested in systems, clinical capabilities and infrastructure that enhance integration across our hospitals and clinics.

CFO Financial Highlights

"Net Revenue increased by 7% to SAR 1,538.5 million. EBITDA increased significantly to SAR 416.5 million, with EBITDA margin expanding to 27.1%. Net profit increased by 43.7% to SAR 266.2 million."

Mr. Hani Charani, CFO
Mr. Hani Charani
Chief Financial Officer, SMC Healthcare
+7%
Revenue Growth
27.1%
EBITDA Margin
+43.7%
Net Profit Growth
Mr. Bassam Chahine, CEO
Mr. Bassam Chahine
Chief Executive Officer
Mr. Hani Charani, CFO
Mr. Hani Charani
Chief Financial Officer
2025 Performance

Operational
Excellence

Our 2025 performance demonstrates strong operational momentum supported by rising patient demand, expanded clinical services and increased digital engagement.

64.6%
Appointments via Mobile App
99.6%
Cardiac Cath Success Rate
+11.8%
0
OPD Visits
2024: 1,258,4962025
+18.3%
0
Emergency Visits
2024: 199,4482025
+18.4%
0
Laboratory Tests
2024: 1,594,7682025
+16.2%
0
Radiology
2024: 310,3592025
+11%
0
Surgical Procedures
2024: 25,4222025
+7.1%
0
Deliveries
2024: 5,0632025
Year-over-Year

Key Volume Comparison

OPDEmergencySurgeryDeliveries040080012001600
Growth Index

Performance Radar (2024=100)

OPDEmergencyLaboratoryRadiologySurgeryDeliveries

2025 in Review — Key Milestones

Jan 2025Brand

New Brand Identity Launch

Reflecting SMC's future-focused, patient-centered care philosophy with a refreshed visual identity

Apr 2025Innovation

First ILY_ROBOT Urological Surgery

National medical breakthrough — first urological surgery in Saudi Arabia using ILY_ROBOT technology

Jun 2025Capital Markets

IPO on Saudi Exchange (Tadawul)

Successful public listing on the main market of Tadawul — Ticker: 4163. A defining milestone in SMC's journey

Oct 2025Expansion

SMC 4 Financing Agreement

SAR 800M Islamic Credit Facility signed for the Khuzam District flagship hospital development

Nov 2025Shareholder Value

One-off Dividend Recommended

Board of Directors recommended a one-off dividend distribution to shareholders, reflecting strong cash generation

Dec 2025Strategic

Al Wadi Real Estate Fund

SMC announced intention to establish a Shariah-compliant real estate fund — unlocking asset value

Network & Footprint

Our Presence
Across Riyadh

SMC operates an integrated network of hospitals and outpatient clinics across Riyadh, providing comprehensive healthcare services to the Central Province of Saudi Arabia.

3
Operational Hospitals
581
Licensed Beds
6+
Clinics
Select a Hospital
SMC 1 — Al NuzhaOperational
Riyadh, Saudi Arabia · 300 Licensed Beds
CardiologyOncologyNeurologyOrthopedics

Outpatient Clinic Network

Al Hamra Clinics
Outpatient
Al Rawdah Clinics
Outpatient
Al Zahraa Clinics
Outpatient
Al Safa Clinics
Outpatient
Al Andalus Clinics
Outpatient
Al Nuzha Clinics
Outpatient
Growth Strategy

Expansion &
Future Growth

SMC's growth strategy is built on four pillars: capacity expansion, service diversification, digital transformation, and geographic growth — all aligned with Saudi Vision 2030's healthcare objectives.

+300 beds
Capacity Expansion

Adding 300 beds at SMC 4 to nearly double our inpatient capacity

5+ new centers
Service Diversification

Launching new specialty centers including oncology, robotic surgery, and fertility

100% digital
Digital Integration

Unified digital platform connecting all facilities for seamless patient journeys

New regions
Geographic Expansion

Evaluating opportunities to extend SMC's network beyond Riyadh into new regions

Strategic Initiatives

In Progress2026–2028

SMC 4 — Khuzam District

SAR 800M

A flagship 300-bed tertiary hospital in the Khuzam district of Riyadh, financed through an SAR 800M Islamic Credit Facility. This will be SMC's most advanced facility, featuring a comprehensive cancer center, advanced surgical suites, and a dedicated research wing.

300 licensed beds
Comprehensive Cancer Center
Advanced Robotic Surgery
Research & Training Institute
SAR 800M Islamic Credit Facility
SMC Expansion
Phase 1 — 2026–2028
SMC 4 — Khuzam District
300
Licensed Beds
Saudi Vision 2030

Aligned with National Healthcare Transformation

SMC's growth strategy directly supports Vision 2030's healthcare objectives: increasing private sector participation, improving quality of care, reducing medical tourism, and building a world-class healthcare system.

35%
Private Sector Share
Target by 2030
Growing
Saudization Rate
SMC Commitment
Reduction
Medical Tourism
National Goal
100%
Digital Health
SMC Target
Investor Relations

The Investment
Case for SMC

SMC Healthcare offers investors a compelling opportunity to participate in Saudi Arabia's growing private healthcare sector, backed by a proven track record, strong financials, and a clear growth strategy.

Proven Growth Track Record

Consistent revenue growth with 7% increase in FY2025, driven by rising patient volumes, expanded service offerings and improved operational throughput.

~8%
Revenue CAGR
+43.7%
Net Profit Growth

Integrated Healthcare Platform

Unique integrated model combining hospitals, clinics, diagnostics and pharmacy under one roof — delivering superior patient outcomes and operational efficiencies.

3
Hospitals
6+
Clinics

Vision 2030 Tailwind

Directly aligned with Saudi Arabia's healthcare privatization agenda, benefiting from government support, regulatory frameworks and growing private healthcare demand.

Top 5
Market Position
Saudization

Digital Transformation Edge

Leading digital adoption with 64.6% of appointments via mobile app, AI-powered diagnostics and integrated EMR systems driving efficiency.

64.6%
Mobile Bookings
908,928
Online Appts

Experienced Leadership

Board and management team with deep healthcare expertise, supported by strong governance frameworks and transparent reporting as a newly listed public company.

7
Board Members
Jun 2025
Listing Date

Clinical Excellence

JCI-accredited facilities, 99.6% cardiac catheterization success rate, and first urological robotic surgery in Saudi Arabia.

JCI
Accreditation
99.6%
Cath Success
Stock Performance

SMC Share Price — 2025

SAR per share | Post-IPO (June 25, 2025)

Jun 25JulAugSepOctNovDecSAR 15SAR 18SAR 21SAR 25IPO SAR 18
Share Price
IPO Price
Key Data

Shareholder Information

Stock ExchangeSaudi Exchange (Tadawul)
Ticker Symbol4163
IPO Date25 June 2025
IPO PriceSAR 18.00
Shares Issued250,000,000
Market CapSAR 4.51B
Year-End PriceSAR 18.04
EPS (FY2025)SAR 1.06
P/E Ratio17.0x
Dividend (FY2025)SAR 0.50/share
ESG
Sustainability

Environmental,
Social & Governance

SMC Healthcare is committed to responsible business practices that create long-term value for all stakeholders — patients, employees, communities, and shareholders.

Energy Efficiency

LED lighting upgrades and energy management systems across all facilities

Waste Management

Comprehensive medical waste segregation and safe disposal protocols

Water Conservation

Smart water management and recycling initiatives

Carbon Reduction

Transition to renewable energy sources and reduced carbon footprint

Community Impact

50,000+
Free Health Screenings
200+
Scholarships Awarded
30+
Community Programs
SAR 5M+
CSR Investment

Our People

3,000+
Total Employees
45%
Female Workforce
30%+
Saudi Nationals
40+
Nationalities

SMC invests in its people through continuous training, career development programs, and a culture of excellence. Our diverse workforce of over 3,000 employees from 40+ nationalities reflects our commitment to inclusion.

Saudi Vision 2030
Aligned with National Strategy

Supporting Saudi Vision 2030

SMC's growth strategy is directly aligned with Saudi Vision 2030's healthcare transformation goals — expanding private sector healthcare capacity, improving quality of care, and building a sustainable, world-class health system for Saudi Arabia.

Expand Private Healthcare
Increase Saudization
Digital Health Innovation
Corporate Governance

Shareholder &
Governance

As a newly listed company on the Saudi Exchange, SMC Healthcare is committed to the highest standards of corporate governance, transparency, and shareholder value creation.

Ownership

Shareholder Structure

Al Rashid Family
60%
Public Float
30%
Strategic Investors
10%
Market Data

Key Stock Data

Ticker
4163
Exchange
Tadawul (Main Market)
IPO Price
SAR 18.00
Year-End Price
SAR 18.04
Market Cap
SAR 4.51B
Shares Outstanding
250,000,000
EPS (FY2025)
SAR 1.06
P/E Ratio
17.0x
Dividends

Dividend History

FY2025 Recommended Dividend
SAR 0.50
Per Share
Pending AGM Approval
Note: The Board of Directors recommended a one-off dividend of SAR 0.50 per share for FY2025, subject to approval at the Annual General Meeting. This represents SMC's first dividend as a listed company.

Board of Directors

MS
Mr. Sulaiman Al Rashid
Chairman of the Board
Non-Executive
MB
Mr. Bassam Chahine
CEO & Board Member
Executive
MA
Mr. Abdullah Al Rashid
Vice Chairman
Non-Executive
MK
Mr. Khalid Al Rashid
Board Member
Non-Executive
DA
Dr. Abdulaziz Al Omair
Independent Director
Independent
MF
Mr. Faisal Al Zahrani
Independent Director
Independent
DH
Dr. Hisham Al Faleh
Independent Director
Independent
Audit Committee
3 Members
Chair: Independent Director
Remuneration & Nominations
3 Members
Chair: Independent Director
Risk Management Committee
3 Members
Chair: Independent Director
INVESTOR RELATIONS

Contact Our IR Team

Have questions about SMC Healthcare's financial performance, investor relations, or upcoming events? Our dedicated IR team is ready to assist.

Listed on
Tadawul — 4163
Response Time
Within 2 business days
SMC Healthcare · Riyadh, Saudi Arabia · Tadawul: 4163
SEND AN ENQUIRY

Your information is kept confidential and used solely for responding to your enquiry.

Download the Full Annual Report

Access the complete SMC Healthcare Annual Report 2025 including audited financial statements.

SMC Healthcare

Innovative Integrated Healthcare Services for You. Serving the Central Province of Saudi Arabia with excellence since our founding.

Riyadh, Saudi Arabia
+966 11-4343800
Report Sections
Investor Relations
Tadawul ListingCMA DisclosuresAnnual Reports
FY2025 Highlights
Net RevenueSAR 1,538.5M
Net ProfitSAR 266.2M
EBITDA Margin27.1%
OPD Visits1,407,081
Market CapSAR 4.51B
Ticker4163
© 2025 SMC Healthcare Company. All rights reserved. Saudi Exchange (Tadawul) Listed Company — Ticker: 4163
This digital annual report contains forward-looking statements. Actual results may differ materially from those anticipated.